Importantly, our ex vivo study demonstrated that RSK2 protein levels were more enhanced in skin cancer cells such as malignant melanoma compared with squamous cell carcinoma and premalignant immortalized cells [22]. This evidence concerns the gene RPS6KA3 and melanoma.